Long-term Effects of Plant Stanols on the Lipid Profile of Patients with Hypercholesterolemia. A Randomized Clinical Trial;Efecto a largo plazo de los estanoles vegetales en el perfil lipídico de pacientes con hipercolesterolemia. Ensayo clínico aleatorizado

Revista Espanola de Cardiologia

Volumn 68, Issue 8, 2015, Pages 665-671

  Párraga Martínez, Ignacio ^a   López Torres Hidalgo, Jesús D ^b   Del Campo Del Campo, José M ^c   Galdón Blesa, María P ^a   Precioso Yáñez, Juan C ^a   Rabanales Sotos, Joseba ^d   García Reyes Ramos, Mercedes ^e   Andrés Pretel, Fernando ^d   Navarro Bravo, Beatriz ^d   Lloret Callejo, Ángeles ^d  

^a Servicio de Salud de Castilla La Mancha   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c Centro de Salud de Almansa   (Spain)

^d Unidad de Apoyo A la Investigacion Clinica Gerencia de Atencion Integrada de Albacete Servicio de Salud de Castilla La Mancha   (Spain)

^e Centro de Salud zona III   (Spain)

Author keywords

Clinical trial; Hypercholesterolemia; Phytosterols; Primary health care

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PLANT MEDICINAL PRODUCT; STANOL DERIVATIVE; UNCLASSIFIED DRUG; YOGHURT; LIPID; MARGARINE; SITOSTEROL DERIVATIVE; STANOL ESTER;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; BLOOD; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; TIME FACTOR; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MARGARINE; MIDDLE AGED; SITOSTEROLS; TIME FACTORS; TREATMENT OUTCOME; YOGURT;

EID: 84937973202     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.07.036     Document Type: Article

References (31)

1. K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyörälä, U. Keil EUROASPIRE Study Group Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Lancet. 373 2009 926 940
2. L. Pérez de Isla, A. Saltijeral Cerezo, G. Vitale, B. González Timón, A. Torres do Rego, and L.A. Alvarez-Sala Walther Cifras de colesterol adecuadas en pacientes coronarios y diabéticos. Análisis según especialidades médicas y comunidades autónomas Rev Esp Cardiol. 66 2013 748 749
3. A. Cordero, R. López-Palop, V. Bertomeu-González, P. Carrillo, J. Moreno-Arribas, and V. Bertomeu-Martínez Perfil clínico y pronóstico de los pacientes con síndrome coronario agudo y colesterol unido a lipoproteínas de baja densidad < 70 mg/dl Rev Esp Cardiol. 66 2013 588 589
4. K. DeMott, L. Nherera, E.J. Shaw, R. Minhas, S.E. Humphries, M. Kathoria, and et al. Clinical Guidelines and Evidence Review for Familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia 2008 National Collaborating Centre for Primary Care and Royal College of General Practitioners London Disponible en: www.nice.org.uk/CG71
5. T. Wu, J. Fu, Y. Yang, L. Zhang, and J. Han The effects of phytosterols/stanols on blood lipid profiles: a systematic review with meta-analysis Asia Pac J Clin Nutr. 18 2009 179 186
6. J. Plat, G. Brufau, G.M. Dallinga-Thie, M. Dasselaar, and R.P. Mensink A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients J Nutr. 139 2009 1143 1149
7. O. Weingärtner, M. Böhm, and U. Laufs Controversial role of plant sterol esters in the management of hypercholesterolaemia Eur Heart J. 30 2009 404 409
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 285 2001 2486 2497
9. Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund, and et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J. 32 2011 1769 1818
10. A.H. Lichtenstein, L.J. Appel, M. Brands, M. Carnethon, S. Daniels, H.A. Franch, and et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee Circulation. 114 2006 82 96
11. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, R.H. Eckel, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A Ra report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol. 63 25 Pt B 2014 2889 2934
12. R.P. Mensink, S. Ebbing, M. Lindhout, J. Plat, and M.M. Van Heugten Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations Atherosclerosis. 160 2002 205 213
13. M.A. Hallikainen, E.S. Sarkkinen, and M.I. Uusitupa Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner J Nutr. 130 2000 767 776
14. F.H. O'Neill, A. Brynes, R. Mandeno, N. Rendell, G. Taylor, M. Seed, and et al. Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism Nutr Metab Cardiovasc Dis. 14 2004 133 142
15. V. Barrios, M. Martínez, J.P. Tomás, I. Herranz, L. Prieto, J.L. Llisteri, and et al. Perfil clínico de la población hipercolesterolémica española y diferencias entre sexos. Estudio LIPYCARE Hipertensión. 21 2004 395 402
16. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, and et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil. 14 Suppl 2 2007 S1 S113
17. D.E. Morisky, L.W. Green, and D.M. Levine Concurrent and predictive validity of a self-reported measure of medication adherence Med Care. 24 1986 67 74
18. P. Castro Rodríguez, D. Bellido Guerrero, S. Pertega Díaz Grupo Colaborativo del Estudio Elaboración y validación de un nuevo cuestionario de hábitos alimentarios para pacientes con sobrepeso y obesidad Endocrinol Nutr. 57 2010 130 139
19. J.M. Malinowski, and M.M. Gehret Phytosterols for dyslipidemia Am J Health Syst Pharm. 67 2010 1165 1173
20. L.K. Cusack, M.L. Fernandez, and J.S. Volek The food matrix and sterol characteristics affect the plasma cholesterol lowering of phytosterol/phytostanol Adv Nutr. 4 2013 633 643
21. Y.J. Hyun, O.Y. Kim, J.B. Kang, J.H. Lee, Y. Jang, L. Liponkoski, and et al. Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic and mildly hypercholesterolemic subjects Nutr Res. 25 2005 743 753
22. Z. Buyuktuncer, M. Fisunoʇlu, G.S. Guven, S. Unal, and H.T. Besler The cholesterol lowering efficacy of plant stanol ester yoghurt in a Turkish population: a double-blind, placebo-controlled trial Lipids Health Dis. 12 2013 91
23. K. Laitinen, and H. Gylling Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence Lipids Health Dis. 11 2012 140
24. J. Algorta Pineda, M.J. Chinchetru Ranedo, J. Aguirre Anda, and S. Francisco Terreros Eficacia hipocolesterolemiante de un yogur que contiene ésteres de estanol vegetal Rev Clin Esp. 205 2005 63 66
25. J. Plat, and R.P. Mensink Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects Atherosclerosis. 148 2000 101 112
26. M.A. Hallikainen, and M.I.J. Uusitupa Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects Am J Clin Nutr. 69 1999 403 410
27. A. Poli, F. Marangoni, R. Paoletti, E. Mannarino, G. Lupattelli, A. Notarbartolo, and et al. Non-pharmacological control of plasma cholesterol levels Nutr Metab Cardiovasc Dis. 18 2008 S1 S16
28. H. Gylling, J. Plat, S. Turley, H.N. Ginsberg, L. Ellegard, W. Jessup European Atherosclerosis Society Consensus Panel on Phytosterols Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease Atherosclerosis. 232 2014 346 360
29. J.M. Scholle, W.L. Baker, R. Talati, and C.I. Coleman The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis J Am Coll Nutr. 28 2009 517 524
30. I. Demonty, R.T. Ras, H.C. Van der Knaap, G.S. Duchateau, L. Meijer, P.L. Zock, and et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake J Nutr. 139 2009 271 284
31. S.R. Eussen, M.L. Bouvy, C.J. Rompelberg, M.E. Van der Elst, J. Garssen, M.H. Oosterveld, and et al. Influence of the use of functional foods enriched with phytosterols/-stanols on adherence to statin therapy Pharmacoepidemiol Drug Saf. 20 2011 830 837